R
Reven Pharmaceuticals
Reven Pharmaceuticals - Accelerating Wellness
About Reven Pharmaceuticals
Reven Pharmaceuticals is dedicated to scientific innovation aimed at significantly improving health and well-being. The company focuses on developing a new generation of pharmacological solutions that address the root causes of diseases by restoring immune system homeostasis. Reven's flagship product, RJX, is a standalone drug formulated through a proprietary process to target areas of immunologic function without the need for stabilizers and preservatives. This approach aims to impact a wide range of disease indications stemming from inflammation, including cancer and cardiovascular disease, similar to how antibiotics revolutionized the treatment of infectious diseases nearly a century ago.
Reven Pharmaceuticals serves a diverse client base, including healthcare providers, research institutions, and patients suffering from chronic inflammatory conditions. Operating in the pharmaceutical and biotechnology market, the company employs a business model centered around drug development and clinical trials. Reven generates revenue through the sale of its proprietary drugs and formulations, as well as through partnerships and licensing agreements with other pharmaceutical companies.
Source: Dealroom company dataNews
Open roles
Reven Pharmaceuticals in the Westminster ecosystem
The Reven Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Reven Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Reven Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
